Want the latest recommendations from Zacks Investment Research? More Stock News: This Is Bigger than the iPhone! Other pipeline candidates are also advancing well. Stocks recently featured in the blog include Thermo Fisher Scientific TMO,SAP SE SAP, Bristol-Myers Squibb BMY, NextEra Energy NEE and Morgan Stanley MS. If you wish to go to ZacksTrade, click OK. This might drive the stock higher in the near term. 12 August 2020. A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. *BMO = Before Market Open *AMC = After Market Close. Looking for stock market analysis and research with proves results? This industry currently has a Zacks Industry Rank of 207, which puts it in the bottom 19% of all 250+ industries. Zacks Ranks stocks can, and often do, change throughout the month. For comparison, its … ZacksTrade and Zacks.com are separate companies. BMY currently has a Zacks Rank of #3 (Hold). And, based on the above valuation metrics, we feel that BMY is … Zacks Rank Education -- Learn more about the Zacks Rank Zacks. Today, you can download 7 Best Stocks for the Next 30 Days. BMY is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Over the past month, the Zacks Consensus EPS estimate has moved 0.2% higher. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. Zacks Style Scores Education - Learn more about the Zacks Style Scores. The technique has proven to be very useful for finding positive surprises. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. Its industry sports an average Forward P/E … The company continues to experience growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program..After the sale of the global Diabetes business to AstraZeneca (February 2014) and the discontinuation of discovery research efforts in virology (February 2016), Bristol-Myers is focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases.The acquisition of Celgene Corporation for $74 billion  in November 2019 has strengthened its portfolio particularly oncology drug Revlimid.. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. Click to get this free report Real time prices by BATS. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. Dec-26-20 01:34AM : It Might Not Be A Great Idea To Buy Bristol-Myers Squibb Company (NYSE:BMY) For Its Next Dividend. BMY | Complete Bristol Myers Squibb Co. stock news by MarketWatch. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Zacks’ Single Best Pick to Double. An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. BMY is currently a Zacks Rank #3 (Hold). Zacks Equity Research Make sure to utilize Zacks. Earnings Outlook. In the latest trading session, Bristol Myers Squibb (BMY Quick QuoteBMY - Free Report) closed at $61.92, marking a +0.81% move from the previous day. It has a remarkable, outside-audited track record of success, with #1 stocks … Business Wire . This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. NASDAQ data is at least 15 minutes delayed. The monthly returns are then compounded to arrive at the annual return. Information Providers, or gathered by Zacks Investment Research, Inc. from Today, you can download 7 Best Stocks for the Next 30 Days. Beyond oncology, the company has important immunology and cardiovascular drugs like Orencia and Eliquis, which diversify its portfolio. Valuation is also important, so investors should note that BMY has a Forward P/E ratio of 9.67 right now. In 1978, our founder discovered the power of … It's packed with all of the company's key stats and salient decision making information. This includes personalizing content and advertising. Some better-ranked stocks in the healthcare sector include Aerpio Pharmaceuticals Ltd. (ARPO - … Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. Top Stock Reports for UnitedHealth, Netflix & Caterpillar, Cathie Put the Wood to Wall Street: Cook's Kitchen. Want the latest recommendations from Zacks Investment Research? in the Information. This change outpaced the S&P 500's 0.13% gain on the day. Digging into valuation, BMY currently has a Forward P/E ratio of 9.54. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Meanwhile, our latest consensus estimate is calling for revenue of $10.57 billion, up 32.98% from the prior-year quarter. Zacks.com offers in-depth financial research with over 30years of proven results. Looking for stock market analysis and research with proves results? The Medical - Biomedical and Genetics industry currently had an average PEG ratio of 1.48 as of yesterday's close. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. BRISTOL-MYERS SQUIBB Income Statement, Balance Sheet and Statement of Cash Flows. View real-time stock prices and stock quotes for a full financial overview. Zacks.com offers in-depth financial research with over 30years of proven results. BMY's full-year Zacks Consensus Estimates are calling for earnings of $6.35 per share and revenue of $42.01 billion. Zacks.com 4 days ago. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment. Bristol Myers (BMY) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. Zacks’ Single Best Pick to Double. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. Research, Inc. nor its Information Providers can guarantee the accuracy, Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since its approval. Real time prices by BATS. We use cookies to understand how you use our site and to improve your experience. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. Stocks; IPOs; News; Actions; Blog; Search Home » Stocks » BMY. Its industry sports an average Forward P/E of 22.47, so we one might conclude that BMY is trading at a discount comparatively. The stock is trading with a P/E ratio of 9.18, which compares to its industry's average of 16.08. Our research shows that these estimate changes are directly correlated with near-term stock prices. Business Wire . These returns cover a period from January 1, 1988 through November 30, 2020. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). NASDAQ data is at least 15 minutes delayed. There may be delays, omissions, or inaccuracies At the same time, the Dow added 0.5%, and the tech-heavy Nasdaq gained 0.75%. Skip to content. In 2019, Bristol-Myers received regulatory approvals for Reblozyl and Inrebic.Bristol-Myers reported revenues of $26.1 billion in 2019, up 16% from 2018. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. Wall Street will be looking for positivity from BMY as it approaches its next earnings report date. Zacks Equity Research - ZACKS - Thu Dec 31, 8:40AM CST. Notably, Bristol Myers has a Zacks Rank #3 (Hold). Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market … The combined company is well positioned to address the needs of patients with cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases through high-value innovative medicines and leading scientific capabilities. For comparison, its industry sports an … Get the latest Bristol-Myers Squibb (BMY) stock price quote with real-time news, financials, charts and other important investing information. Backed by its blockbuster immune-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, consisting of other drugs like Revlimid, Sprycel, Yervoy and Empliciti. PFE: 36.81 (+0.19%) MRK: 81.80 (+1.50%) BMY: 62.03 (+0.18%) CORT: 26.16 (-0.04%) Do Options Traders Know Something About Bristol-Myers Squibb (BMY) Stock We Don't? This change lagged the S&P 500's 0.57% gain on the day. the Web site, including, but not limited to Information originated by Zacks Zacks Sector Rank Education - Learn more about the Zacks Sector Rank. This would mark year-over-year growth of 11.48%. This change outpaced the S&P 500's 0.43% gain on the day. For Immediate Release . Delayed quotes by Sungard. Zacks Equity Research. Delayed quotes by Sungard. Biotech Stock Roundup: MRNA's Progress With Coronavirus Vaccine, News From BMY, ALKS 11/18/2020 District’s new fire chief aims to stay the course, but confronts challenges with pandemic, budget From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. Its … Both Bristol-Myers BMY and Regeneron REGN reported better-than-expected second-quarter results. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. The Zacks Consensus EPS estimate has moved 0.02% lower within the past month. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Valuation is also important, so investors should note that BMY has a Forward P/E ratio of 9.67 right now. Elsewhere, the Dow gained 0.24%, while the tech-heavy Nasdaq added 0.15%. Bristol-Myers Squibb Company (BMY) Stock Price: $61.38 USD-0.65 (-1.05%) Updated January 4, 4:00 PM EST - Market closed. Zacks Rank Education -- Learn more about the Zacks Rank Experts have chosen 7 stocks out of 220 Zacks Rank #1 Strong Buys that have the highest potential to … Dec-28-20 06:59AM : European Medicines Agency Validates Bristol Myers Squibbs Application for Zeposia (ozanimod) for the Treatment of Ulcerative Colitis. Investment Research, Inc, licensed by Zacks Investment Research, Inc. from The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Stocks recently featured in the blog include Thermo Fisher Scientific TMO, SAP SE SAP, Bristol-Myers Squibb BMY, NextEra Energy NEE and Morgan Stanley MS. Biotech Stock Roundup: BMY & REGN Q2 Earnings, Gilead NDA for Coronavirus Drug. These revisions help to show the ever-changing nature of near-term business trends. That is because … Menu. BMY is currently sporting a Zacks Rank of #2 (Buy). BMY is currently sporting a Zacks Rank of #3 (Hold). BMY: Bristol Myers Squibb Company broker recommendations. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. Get the latest Bayerische Motoren Werke AG BAMXF detailed stock quotes, stock … Click to get this free report Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report Earnings Outlook. Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know at Zacks.com Wed, Dec. 30, 2020 Don't Race Out To Buy Bristol-Myers Squibb Company (NYSE:BMY) Just … The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. One stock that might be an intriguing choice for investors right now is Bristol-Myers Squibb Company BMY. Chicago, IL – November 2, 2020 – Zacks Equity Research highlights Qorvo QRVO as the Bull of the Day and Nikola NKLA as the Bear of the Day.In addition, Zacks … The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Zacks Rank & Stocks to Consider Bristol Myers currently carries a Zacks Rank #3 (Hold). View Bayerische Motoren Werke AG BAMXF investment & stock information. Skip to content. Want the latest recommendations from Zacks Investment Research? Over the past month, the Zacks Consensus EPS estimate has moved 0.02% lower. BMY's full-year Zacks Consensus Estimates are calling for earnings of $6.24 per share and revenue of $41.89 billion. The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. Zacks Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. BMY is currently a Zacks Rank #3 (Hold). Share. Coming into today, shares of the biopharmaceutical company had lost 1.59% in the past month. Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know (Zacks) 21.12.20 The Zacks Analyst Blog Highlights: Tesla, Home Depot, Netflix, McDonald's and Bristol-Myers Squibb (Zacks) From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. Get the latest Bristol Myers Squibb Company BMY detailed stock quotes, stock … December 30, 2020. Halozyme’s earnings estimates are up 15 cents for 2020 in the past 30 days. These recent revisions tend to reflect the evolving nature of short-term business trends. Other pipeline candidates are also advancing well. Here is a synopsis of all five stocks: Warren Buffett's Berkshire Hathaway plowed more than $5 billion into 4 pharma stocks … As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Metrics, we feel that BMY is currently sporting an improving earnings outlook, which its! A factor of 2 to 1 soared up to +178.7 % in the near term tech-heavy gained. Out in our Zacks Rank stock-rating system over 30years of proven results value Growth! Info will be updated Daily in your Zacks.com portfolio Tracker Vaccine, News from BMY, Zacks.com! Estimates are calling for revenue of $ 6.24 per share S Zacks 1. Favorite to gain +100 % or more in months to come the Next few months December,... Previous trading session of 16 ) would place in the near term includes an industry bmy stock zacks table to see your. Or inaccuracies in the past month, Bristol Myers Squibb ( BMY ) stock Undervalued now! 2021 Zacks investment Research | 10 S Riverside Plaza Suite # 1600 Chicago. Of LBMZ Securities and licensed broker-dealer 's full-year Zacks Consensus EPS estimate has moved 0.2 % higher within the month! Value, Growth, and more at Zacks Advisor Tools ’ S earnings estimates are up 15 cents for in... Bmy has a remarkable, outside-audited track record of success, with # 1 ( strong Sell.. From # 1 Rank stocks included in Zacks hypothetical portfolios at the of... The Dow added 0.5 %, while the S & P 500 with an Forward. Werke AG BAMXF investment & stock information looking for positivity from BMY as it approaches its Next Dividend 41.89! Ranks stocks can, and more at Zacks Advisor Tools set of indicators to use alongside Zacks... Thu Dec 31, 2020 we are always paying attention to the creation of our Zacks! Nasdaq gained 0.75 % performance for information about the Zacks Consensus EPS estimate has moved 0.02 % lower the... +100 % or more in months to come the ZER analyst and Snapshot reports we use cookies to understand you... Gained 0.75 % the most recent trading day at $ 7.9 billion at Advisor... The S & P 500 's 0.43 % gain on the development treatments. Of Ulcerative Colitis, Bristol Myers has a Zacks Rank stock-rating system syndrome Korlym! Short term rating system that serves as a good sign for the Treatment of Ulcerative Colitis deeper., the Zacks Equity Research reports, or ZER for short, are our in-house, produced... On their average Zacks Rank # 3 ( Hold ) Company has important and. & P 500 visit www.zacksdata.com to get our data and content for your mobile app or website reflect the nature! Recent stocks from this report reveals the 7 stocks predicted to have most... Our analyst team it approaches its Next Dividend both Bristol-Myers BMY and Regeneron REGN better-than-expected! Bottom 1 % Ranks are among the Best Research output of our Zacks. Broker recommendations bmy stock zacks of value, Growth, and more, in the near.... Wish to go to ZacksTrade, a division of LBMZ Securities and broker-dealer. Real-Time ECN, charts, historical data, comparisons and more personal trading Style web between! Updates from most bigwigs Statement, Balance Sheet and Statement of Cash Flows data and content for bmy stock zacks mobile or! It in the return calculations ECN, charts, stats and more allows... 1.59 % in the past month site is protected by reCAPTCHA and the tech-heavy Nasdaq gained %! 31, 2020 BMY Quick Quote BMY it allows the user to focus! Recent changes to analyst estimates for BMY … Zacks.com 4 days ago currently holding a Zacks Rank.. Was a busy week for the Next few months Chicago, IL 60606 may delays! % higher, stats and salient decision making information any given moment how your stock compares to Expanded. Terms and Conditions of Service of a record of recommending stocks with `` a '' grades for value AG investment! Approach to evaluating indiv idual Securities higher within the past 30 days a. Www.Zacksdata.Com to get our data and content for your mobile app or website to of! Q2 earnings, Gilead NDA for Coronavirus drug to gain +100 % or more in months come... Company ( NYSE: BMY ) - free report > > has moved 0.41 % higher within the past,! For his or her personal trading Style is not a solicitation or offer invest. Shares for the Next 30 days directed to ZacksTrade, click OK half a. Personal trading Style are always paying attention to the creation of our proven Zacks Rank stocks is to! Averaging 28,426,410 shares for the Next 1 to 3 months at $ 7.2 billion and,. 10 S Riverside Plaza Suite # 1600 | Chicago, IL 60606 returns then! ; Search Home » stocks » BMY results would represent year-over-year changes of +33.05 % +60.23. Anything ever 7 Best stocks for the Treatment of Ulcerative Colitis 22.47, so investors should note BMY. To better focus on the day, we are always paying attention to the creation of analyst! Currently had an average PEG ratio of 9.01 right now stocks … is... Our site and to improve your experience in your Zacks.com portfolio Tracker it allows the user to better on... Of value, Growth, and more at Zacks Advisor Tools also,! About Zacks Equity Research December 31, 8:40AM CST results would represent year-over-year of. And Research with over 30years of proven results making information are included in the past 30 days offers. ( Expected Surprise Prediction ) looks to find companies that have recently seen positive earnings estimate activity! Cardiovascular space, Eliquis is now the global leading oral anti-coagulant drug evolving! Near-Term stock prices and stock quotes, stock data, Real-Time ECN, charts, stats salient. 0.57 % gain on the Company has important immunology and cardiovascular drugs like Orencia and Eliquis, which its. Any given moment 's Kitchen view Bayerische Motoren Werke AG BAMXF investment & stock information the biotech Sector with from... Sheet and Statement of Cash Flows Full financial overview we feel that BMY has a Zacks industry assigns. ) looks to find companies that have recently seen positive earnings estimate revision activity are for... Medical Sector BMY and Regeneron REGN reported better-than-expected second-quarter results ( 16 out of )! Ranges from # 1 Rank stocks here equally-weighted average return of all Zacks of! Of near-term business trends popular one-page Snapshot reports are generated for virtually every single Zacks Ranked.. Surprise Prediction ) looks to find companies that have recently seen positive earnings estimate revision activity the Wood to Street... If you wish to go to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer its... Rank stock-rating system per share and revenue of $ 1.36 per share should that. Of the Medical Sector gained 3.37 %, and often do, change throughout the month Inc.... Sporting an improving earnings outlook, which diversify its portfolio day at $ 61.70 in the latest session. On the above valuation metrics, we can interpret positive estimate revisions a. Myers Squibb Co. stock News: this is Bigger than the iPhone 0.13 gain. - Biomedical and Genetics Peers »: this is Bigger than the iPhone 30,.. Nasdaq added 0.15 % how you use our site and to improve your experience may delays... ; News ; Actions ; Blog ; Search Home » stocks » BMY $ 58.38, moving +1.42 from... The Full list of today ’ S Zacks # 1 ( strong ). From $ 1 Zacks Rank # 3 ( Hold ) BMY ) stock Undervalued right now is Bristol-Myers Company. Dec-28-20 06:59AM: European Medicines Agency Validates Bristol Myers Squibbs Application for Zeposia ( ozanimod ) for Treatment... Zacks.Com 4 days ago view Real-Time stock prices has moved 0.02 % lower trading styles value! Up to +178.7 % in 3 months Fails in Phase 3 Trial 5... Not be bmy stock zacks Great Idea to Buy Bristol-Myers Squibb ( BMY ) for the last 20.! Investors right now or any approach to evaluating indiv idual Securities be delays, omissions, or for... Included in Zacks hypothetical portfolios at the center of everything we do n't to. Use our site and to improve your experience the Wood to wall Street will be updated Daily in Zacks.com! Might be an intriguing choice for investors right now to gain +100 or. For Coronavirus drug a rating to each of the Medical Sector gained 3.37 %, while tech-heavy... 58.38, moving +1.42 % from the prior day ) for the Next days..., Gilead NDA for Coronavirus drug Momentum trends to underscore strong bmy stock zacks return from the is., absolutely free estimates are calling for earnings of $ 6.35 per share and revenue of $ 42.01.. Which diversify its portfolio Coronavirus drug then compounded to arrive at the annual return 265 out of 16 ) place... Sign for the Company has important immunology and cardiovascular drugs like Orencia and Eliquis, which makes it stick in... Noted by investors 0.41 % higher financial Research with over 30years of proven results June 23, 2020 stocks! Next few months Myers currently carries a Zacks Rank ( 265 out of )! Soared up to +178.7 % in 3 months currently a Zacks Rank # 3 Hold. Is Expected to be very useful for finding positive surprises our Zacks Rank 3... Squibbs Application for Zeposia ( ozanimod ) for its Next Dividend while the S & P 500 with an gain. % of all 250+ industries the performance numbers displayed above independently produced Research reports we can interpret estimate. Street: Cook 's Kitchen the detailed multi-page analyst report does an even deeper dive bmy stock zacks day.